Hsu R W, Huang W L, King S L, Chiang C D
Department of Internal Medicine, Taichung Veterans General Hospital, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Oct;50(4):293-6.
Nasal continuous positive airway pressure (CPAP) is an effective therapy for sleep apnea. Little is known about long-term patient compliance and side effects with this therapeutic modality in the Chinese. In order to evaluate this, we collected 8 obstructive sleep apnea patients who received home nasal CPAP therapy between January 1990 and July 1991. Each received two sets of nap polysomnographic studies. The initial set was performed to diagnose and evaluate patient response to CPAP as well as defining the CPAP pressure the patient would be using at home. The second set of studies were conducted for follow up and re-evaluation. Seven of these patients reported using nasal CPAP during sleep at night, and one did not use it all. Nasal CPAP improved clinical symptoms, particularly daytime sleepiness, and 7 patients were generally satisfied with nasal CPAP. Initially the side effects were a dry throat and nose. After 5 to 15 months of CPAP treatment, the follow-up nap sleep studies showed no significant change in the apnea/hypopnea index, duration of apnea, or oxygen desaturation between the diagnostic and follow-up (without CPAP) studies. However the amount of nasal CPAP pressure setting declined in 4 of 7 patients. Our own experience indicates that long-term nasal CPAP is an important new means of treatment for sleep apnea and allows a normal daytime life. It was well-tolerated by most sleep apnea patients. However, it is necessary to further evaluate of morbidity and the amount of pressure setting relative to long-term home nasal CPAP.
经鼻持续气道正压通气(CPAP)是治疗睡眠呼吸暂停的一种有效方法。对于这种治疗方式在中国患者中的长期依从性和副作用,人们了解甚少。为了对此进行评估,我们收集了1990年1月至1991年7月期间接受家庭经鼻CPAP治疗的8例阻塞性睡眠呼吸暂停患者。每位患者均接受了两组午睡多导睡眠图研究。第一组研究用于诊断和评估患者对CPAP的反应,以及确定患者在家中使用的CPAP压力。第二组研究用于随访和重新评估。这些患者中有7例报告在夜间睡眠时使用经鼻CPAP,1例根本未使用。经鼻CPAP改善了临床症状,尤其是日间嗜睡,7例患者对经鼻CPAP总体满意。最初的副作用是咽干和鼻干。在CPAP治疗5至15个月后,随访的午睡睡眠研究显示,诊断性研究和随访(未使用CPAP)研究之间的呼吸暂停/低通气指数、呼吸暂停持续时间或氧饱和度均无显著变化。然而,7例患者中有4例的经鼻CPAP压力设置量下降。我们自己的经验表明,长期经鼻CPAP是治疗睡眠呼吸暂停的一种重要新方法,可使患者拥有正常的日间生活。大多数睡眠呼吸暂停患者对其耐受性良好。然而,有必要进一步评估长期家庭经鼻CPAP的发病率和压力设置量。